Herpes Zoster
Conditions
Interventions
experimental group:In accordance with the neural distribution of herpes zoster lesions, administer XiaTianWu injection 4 ml around the affected nerve every other day, for a total of 5 treatments
Control Group:The control group received intravenous infusion of acyclovir at a daily dose of 0.5 grams for a duration of 7 consecutive days.
Sponsors
Strategic Support Force Medical Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age greater than or equal to 18 years and less than or equal to 80 years. 2.Patients with herpes zoster, diagnosed based on the typical clinical manifestations of herpes zoster, following the criteria outlined in the "Chinese Expert Consensus on Diagnosis and Treatment of Herpes Zoster 2022." 3.Visual Analogue Scale (VAS) score greater than 3. 4.Voluntary participation in this trial.
Exclusion criteria
Exclusion criteria: 1.Pregnancy. 2.Fasting blood glucose level greater than 8.8 mmol/L. 3.Poorly controlled hypertension, with systolic blood pressure greater than 180 mmHg and/or diastolic blood pressure greater than 120 mmHg. 4.Age less than 18 years or greater than 75 years. 5.Patients with visceral organic lesions requiring urgent intervention. 6.Patients with fractures, ligament tears, or other injuries requiring emergency surgery. 7.Patients with neurological tumors. 8.Patients taking oral anticoagulants. 9.Non-voluntary participation in this trial. 10.Numeric Rating Scale (NRS) pain score less than or equal to 3.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale,VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| herpes scabbing time; | — |
Countries
China
Contacts
Public ContactGuoxin Han
Strategic Support Force Medical Center
Outcome results
None listed